Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder

2004149 citationsJournal Article

Authors

These results suggest a possible augmentation role for ziprasidone when used in conjunction with SSRIs in SSRI-resistant MDD.

Good health and well-being

Published in: The Journal of Clinical Psychiatry

Volume 65, Issue 2, pp. 217-221

Field-Weighted Citation Impact: 13.32